09/25/2019
3:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K/A
| |
09/24/2019
3:04 PM | CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2019
4:25 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2019
3:30 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
10:03 AM | CASI Pharmaceuticals (Filer)
| Form CT ORDER
| |
08/15/2019
3:51 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
3:31 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
08/09/2019
9:01 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2019
4:01 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
07/19/2019
4:00 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2019
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2019
12:35 PM | CASI Pharmaceuticals (Filer)
| Form CT ORDER
| |
05/15/2019
9:03 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
3:50 PM | CASI Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/17/2019
3:03 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2019
3:01 PM | CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
| Form SC 13D/A
| |
04/05/2019
3:31 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2019
3:02 PM | CASI Pharmaceuticals (Filer)
| Form PRE 14A
| |
04/04/2019
6:30 PM | CASI Pharmaceuticals (Issuer)
Spectrum Pharmaceuticals Cayman, L.P. (Reporting)
SPECTRUM PHARMACEUTICALS INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
9:22 AM | CASI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
4:02 PM | CASI Pharmaceuticals (Filer)
| Form NT 10-K
| |
03/13/2019
4:18 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
4:23 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2019
3:07 PM | CASI Pharmaceuticals (Subject)
Zhejiang Kanglaite Group Co., LTD (Filed by)
| Form SC 13G/A
| |
02/06/2019
3:06 PM | CASI Pharmaceuticals (Subject)
Li Dapeng (Filed by)
| Form SC 13G
| |
02/06/2019
3:04 PM | CASI Pharmaceuticals (Issuer)
Li Dapeng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/31/2019
6:21 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
6:19 PM | CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
3:46 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2019
3:02 PM | CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
4:00 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
3:31 PM | CASI Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/06/2018
3:30 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2018
12:23 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2018
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
11/20/2018
4:07 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2018
3:42 PM | CASI Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2018
9:02 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2018
8:02 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2018
5:04 AM | CASI Pharmaceuticals (Issuer)
Li Jianguang (Reporting)
Lin Dongliang (Reporting)
Shong Hugo (Reporting)
SNOW MOON LTD (Reporting)
SPARKLE BYTE LTD (Reporting)
TIANJIN JINGRAN MANAGEMENT CENTER (0001664019) (Reporting)
Yang Fei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2018
5:01 AM | CASI Pharmaceuticals (Subject)
SPARKLE BYTE LTD (Filed by)
| Form SC 13D/A
| |
10/31/2018
6:24 PM | CASI Pharmaceuticals (Issuer)
Wealth Strategy Holding Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2018
4:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K/A
| |
10/24/2018
3:57 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2018
3:41 PM | CASI Pharmaceuticals (Subject)
Wealth Strategy Holding Ltd (Filed by)
| Form SC 13G/A
| |
10/02/2018
6:20 PM | CASI Pharmaceuticals (Issuer)
Chi George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
6:20 PM | CASI Pharmaceuticals (Issuer)
Chi George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2018
6:19 PM | CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/28/2018
7:13 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2018
7:13 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2018
4:26 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2018
9:01 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2018
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2018
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
08/06/2018
3:28 PM | CASI Pharmaceuticals (Filer)
| Form S-3/A
| |
07/17/2018
3:35 PM | CASI Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/03/2018
8:30 PM | CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2018
2:38 PM | CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2018
2:38 PM | CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2018
2:37 PM | CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2018
2:36 PM | CASI Pharmaceuticals (Issuer)
Wu Alex (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2018
4:13 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
4:17 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2018
9:01 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2018
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2018
2:08 PM | CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
| Form SC 13D/A
| |
04/23/2018
8:58 AM | CASI Pharmaceuticals (Filer)
| Form CT ORDER
| |
04/17/2018
4:01 PM | CASI Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/13/2018
5:03 PM | CAPITELLI SARA B (Reporting)
CASI Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/06/2018
4:33 PM | CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2018
3:33 PM | CASI Pharmaceuticals (Subject)
He Wei-Wu (Filed by)
| Form SC 13D/A
| |
03/29/2018
2:41 PM | CASI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2018
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/23/2018
3:41 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/23/2018
2:03 PM | CASI Pharmaceuticals (Issuer)
Ho Chi Sing (Reporting)
IDG-Accel China Growth Fund GP III Associates Ltd. (Reporting)
IDG-Accel China Growth Fund III Associates L.P. (Reporting)
IDG-Accel China Growth Fund III L.P. (Reporting)
IDG-Accel China III Investors L.P. (Reporting)
Zhou Quan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2018
5:53 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2018
1:52 PM | CASI Pharmaceuticals (Subject)
Ho Chi Sing (Filed by)
| Form SC 13D/A
| |
03/16/2018
4:00 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2018
4:22 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2018
4:21 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
02/05/2018
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
01/26/2018
4:11 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2018
4:02 PM | CASI Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/12/2018
3:30 PM | CASI Pharmaceuticals (Subject)
He Wei-Wu (Filed by)
| Form SC 13D
| |
12/25/2017
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
12/22/2017
3:30 PM | CASI Pharmaceuticals (Filer)
CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2017
2:38 PM | CASI Pharmaceuticals (Issuer)
Spectrum Pharmaceuticals Cayman, L.P. (Reporting)
SPECTRUM PHARMACEUTICALS INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2017
4:19 PM | CASI Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/13/2017
4:12 PM | CASI Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
